BAYNES ROY D. sold 10.7% of their position (4.50K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $209.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/7/2026ACC: 0001680739-26-000008
-4.50K
Net shares
Net seller
$209.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
4.50K acquired · 9K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.50K
Price / share
$18.27
Trade value
$82.22K
% of position
12.0%
5/5/2026
37.50K→42K
Common Stock
Direct
Shares
−4.50K
Price / share
$46.65
Trade value
$209.93K
% of position
10.7%
5/5/2026
42K→37.50K
Total
Net shares
+0.00
Net value
-$127.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/5/2026 | M · Option Exercise | +4.50K | $18.27 | $82.22K | 12.0% | 37.50K | 42K |
| Common Stock Direct | 5/5/2026 | S · Sale | −4.50K | $46.65 | $209.93K | 10.7% | 42K | 37.50K |
| Total | +0.00 | -$127.71K | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
4.50K shares
Shares
−4.50K
Strike price
18.27
Held after
0.00
Exercisable
—
5/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock4.50K shares | 5/5/2026 | M · Option Exercise | −4.50K | 18.27 | — | 0.00 |